Showing results (51-60 of 59) with videos related to
Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 59 results.
American Journal of Hematology|June 20, 2015
Liver iron concentration measurements by MRI in chronically transfused children with sickle cell anemia: baseline results from the TWiTCH trialJohn C Wood, Sara Pressel, Zora R Rogers, et al.Transplantation and Cellular Therapy|December 26, 2024
Early Engraftment and Immune Kinetics Following Allogeneic Transplant Using a Novel Reduced-Toxicity Transplant Strategy in Children/Adolescents with High-Risk Transfusion-Dependent Thalassemia: Early Results of the ThalFAbS TrialEnass H Raffa, Taylor M Harris, Chane Choed-Amphai, et al.Blood|January 27, 2012
Chelation use and iron burden in North American and British thalassemia patients: a report from the Thalassemia Longitudinal CohortJanet L Kwiatkowski, Hae-Young Kim, Alexis A Thompson, et al.Pediatrics|July 4, 2008
Clinical and genetic analysis of unclassifiable inherited bone marrow failure syndromesJuliana T Teo, Robert Klaassen, Conrad V Fernandez, et al.Blood|February 28, 2022
A randomized, placebo-controlled, double-blind trial of canakinumab in children and young adults with sickle cell anemiaDavid C Rees, Yurdanur Kilinc, Selma Unal, et al.Blood Advances|March 11, 2026
Newborn Screening Results for Sickle Cell Disease from the ASH Consortium on Newborn Screening in Africa (CONSA)Bernard Awuonda, Charles Kiyaga, Lulu Fred Chirande, et al.Blood Advances|October 20, 2022
The Consortium on Newborn Screening in Africa for sickle cell disease: study rationale and methodologyNancy S Green, Andrew Zapfel, Obiageli E Nnodu, et al.Blood Advances|December 7, 2019
End points for sickle cell disease clinical trials: renal and cardiopulmonary, cure, and low-resource settingsAnn T Farrell, Julie Panepinto, Ankit A Desai, et al.Lancet (London, England)|December 17, 2015
Hydroxycarbamide versus chronic transfusion for maintenance of transcranial doppler flow velocities in children with sickle cell anaemia-TCD With Transfusions Changing to Hydroxyurea (TWiTCH): a multicentre, open-label, phase 3, non-inferiority trialRussell E Ware, Barry R Davis, William H Schultz, et al.Pageof 6